HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,070 | -63.1% | 235,204 | -65.0% | 0.02% | -63.8% |
Q2 2023 | $57,145 | +4.5% | 671,185 | +1.5% | 0.07% | -2.8% |
Q1 2023 | $54,702 | +10.9% | 661,048 | +5.4% | 0.07% | +2.9% |
Q4 2022 | $49,339 | -99.6% | 627,318 | +262.9% | 0.07% | +263.2% |
Q3 2022 | $12,797,000 | +483.0% | 172,859 | +413.3% | 0.02% | +533.3% |
Q2 2022 | $2,195,000 | -49.7% | 33,678 | -14.3% | 0.00% | -50.0% |
Q1 2021 | $4,363,000 | +1480.8% | 39,300 | +1588.1% | 0.01% | – |
Q4 2020 | $276,000 | -98.1% | 2,328 | -98.6% | 0.00% | -100.0% |
Q3 2020 | $14,327,000 | -22.7% | 164,202 | -20.6% | 0.02% | -32.4% |
Q2 2020 | $18,533,000 | +761.6% | 206,933 | +1057.8% | 0.03% | +580.0% |
Q2 2019 | $2,151,000 | -0.0% | 17,873 | -27.3% | 0.01% | 0.0% |
Q1 2019 | $2,152,000 | -90.0% | 24,600 | -86.9% | 0.01% | -89.8% |
Q3 2018 | $21,524,000 | -45.4% | 187,848 | -57.2% | 0.05% | -49.0% |
Q2 2018 | $39,395,000 | +542.0% | 439,282 | +423.8% | 0.10% | +585.7% |
Q1 2018 | $6,136,000 | -11.7% | 83,870 | -45.8% | 0.01% | -26.3% |
Q3 2017 | $6,949,000 | +13.6% | 154,861 | +0.0% | 0.02% | 0.0% |
Q2 2017 | $6,115,000 | – | 154,856 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |